Clinical analysis of the serum CA125, LDH level in patients with non-Hodgkin lymphoma

VernacularTitle:非霍奇金淋巴瘤患者血清CA125、乳酸脱氢酶水平临床分析
Author: Yuebing WU ; Ding YU ; Yuhua FAN ; Yuhua KE
Publication Type:Journal Article
Keywords: Lymphoma,non-Hodgkin; Tumor markers,biological; CA125; Lactic dehydrugenase
From: Journal of Leukemia & Lymphoma 2009;18(7):410-411
CountryChina
Language:Chinese
Abstract: Objective To investigate the level of serum cancer antigen 125 (CA125) and lactic dehydrogenase(LDH) and clinical features of patients with non-Hodgkin lymphoma(NHL), and the correlation between the level of serum CA125 and LDH. Methods Forty patients with NHL were studied and the variances of the serum CA125, LDH level before treatment were analysed. Results A higher serum of CA125was associated with clinical phase,group,hydrothorax and ascites,intemational prognostic index (IPI), and had weaker positive correlation to LDH. Conclusion Measurement of serum CA125 had important clinical significance to the patients with NHL especially to the patients with hydrothorax and ascites.